Update in Cardiology
Authors: Melvyn Rubenfire
Journal: Annals of Internal Medicine (1999)

Updates from the Annual Session7 September 1999Update in CardiologyMelvyn Rubenfire, MDMelvyn Rubenfire, MDFrom University of Michigan, Ann Arbor, Michigan.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-5-199909070-00007 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The results of studies published in 1998 were important to the practice of cardiology in six main areas of interest. Five of these are discussed here: evaluation of chest pain, acute coronary syndromes, valvular heart disease, congestive heart failure, and coronary risk factors. The sixth topic—coronary disease prevention—was covered in a discussion of two articles (1, 2) in the Update in General Internal Medicine (3).Evaluation of Chest PainExercise Treadmill Testing Is Recommended for Both Men and Women with Suspected Coronary Artery DiseaseAlexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women. J Am ...References1. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-13. CrossrefMedlineGoogle Scholar2. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al . Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-22. CrossrefMedlineGoogle Scholar3. Altkorn D, Roach K, Stern S, Levinson W. Update in general internal medicine. Ann Intern Med. 1999;131:199-206. LinkGoogle Scholar4. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froehlicher VF, et al . ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997;30:260-311. MedlineGoogle Scholar5. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med. 1998; 339:436-43. Google Scholar6. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. Circulation. 1994; 89:1545-56. Google Scholar7. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-55. CrossrefMedlineGoogle Scholar8. Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE, et al . A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med. 1998;339:719-24. CrossrefMedlineGoogle Scholar9. Bonow RO, Carabello B, de Leon AC, Edmunds LH, Fedderly BJ, Freed MD, et al . Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation. 1998;98:1949-84. MedlineGoogle Scholar10. Weissman NJ, Tighe JF, Gottdiener JS, Gwynne JT. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. N Engl J Med. 1998;339:725-32. CrossrefMedlineGoogle Scholar11. Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al . Dental and cardiac risk factors for infective endocarditis. A population-based, case–control study. Ann Intern Med. 1998;129:761-9. LinkGoogle Scholar12. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analysis of prospective studies. JAMA. 1998;279:1477-82. CrossrefMedlineGoogle Scholar13. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-11. CrossrefMedlineGoogle Scholar14. Guerin M, Bruckert E, Dolphin PJ, Turpin G, Chapman MJ. Fenofibrate reduced plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 1996;16:763-72. CrossrefMedlineGoogle Scholar15. Superko HR. Beyond LDL cholesterol reduction. Circulation. 1996;94:2351-4. CrossrefMedlineGoogle Scholar16. Williams PT, Krauss RM, Vranizan KM, Wood PD. Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation. 1990;81:1293-304. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From University of Michigan, Ann Arbor, Michigan.Corresponding Author: Melvyn Rubenfire, MD, Preventive Cardiology, University of Michigan Health Systems, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106-0363. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 7 September 1999Volume 131, Issue 5Page: 356-362KeywordsAngiographyAspirinBlood pressureDeath ratesEchocardiographyExerciseHeparinLow density lipoproteinMyocardial infarctionStable coronary artery disease Issue Published: 7 September 1999 CopyrightCopyright © 1999 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...